Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Nov;70(11):6464-7.
doi: 10.1128/IAI.70.11.6464-6467.2002.

The N-terminal domain of RTX toxin ApxI of Actinobacillus pleuropneumoniae elicits protective immunity in mice

Affiliations

The N-terminal domain of RTX toxin ApxI of Actinobacillus pleuropneumoniae elicits protective immunity in mice

J N Seah et al. Infect Immun. 2002 Nov.

Abstract

We expressed three Actinobacillus pleuropneumoniae ApxI deletion derivatives to map the domain that could induce protective immunity. Antiserum to ApxI N-terminal covered by residues 40 to 380 was found to neutralize ApxI hemolytic activity but not ApxIII cytotoxicity. When used as a subunit vaccine in mice, this recombinant N-terminal fragment elicited protection against lethal infection with heterologous A. pleuropneumoniae serovars.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
(A) Structural organization of ApxI and the relative positions of each truncated ApxI fragment. Fragment X1F1 covered the N-terminal and putative transmembrane domains. Fragment X1F2 covered the gene C-mediated activation domain, and fragment X1F3 covered the calcium-binding domain of the glycine-rich repeats. (B and C) Expression and immunoblotting of ApxI deletion derivatives. Panel B shows Coomassie blue staining of partially purified ApxI recombinant proteins indicated by filled arrows. Lanes: 1, X1F1; 2, X1F2; 3, X1F3. Panel C shows that A. pleuropneumoniae-infected swine serum was reactive to all recombinant proteins. Molecular mass markers are shown on the left (in kilodaltons).
FIG. 2.
FIG. 2.
Neutralization of the ApxI hemolytic activity. Hemolytic neutralization assays were performed with native ApxI toxin obtained from A. pleuropneumoniae 3906 preincubated with guinea pig preimmune serum (▪), X1F1 antiserum (⧫), X1F2 antiserum (▵), X1F3 antiserum (▴), and field serum (□). The results show the arithmetic means of the hemolytic neutralization findings from three experiments performed in duplicate ± the standard deviations.
FIG. 3.
FIG. 3.
Neutrophil protection assay with anti-ApxI antisera. Cytotoxic neutralization assays were performed with native ApxIII toxin obtained from A. pleuropneumoniae serotype 8 preincubated with guinea pig preimmune serum (▪), X1F1 antiserum (⧫), X1F2 antiserum (▵), X1F3 antiserum (▴), and field serum from A. pleuropneumoniae serotype 8-infected pigs (□). The results are the arithmetic means of the cytotoxic neutralization findings from three experiments performed in duplicate ± the standard deviations.

Similar articles

Cited by

References

    1. Bagdasarian, M. M., M. Nagai, J. Frey, and M. Bagdasarian. 1999. Immunogenicity of Actinobacillus ApxIA toxin epitopes fused to the E. coli heat-labile enterotoxin B subunit. Vaccine 17:441-447. - PubMed
    1. Beck, M., J. F. van den Bosch, I. M. Jongenelen, P. L. Loeffen, R. Nielsen, J. Nicolet, and J. Frey. 1994. RTX toxin genotypes and phenotypes in Actinobacillus pleuropneumoniae field strains. J. Clin. Microbiol. 32:2749-2754. - PMC - PubMed
    1. Betsou, F., P. Sebo, and N. Guiso. 1995. The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin. Infect. Immun. 63:3309-3315. - PMC - PubMed
    1. Blackall, P. J., H. L. Klaasen, H. van den Bosch, P. Kuhnert, and J. Frey. 2002. Proposal of a new serovar of Actinobacillus pleuropneumoniae: serovar 15. Vet. Microbiol. 84:47-52. - PubMed
    1. Boehm, D. F., R. A. Welch, and I. S. Snyder. 1990. Calcium is required for binding of Escherichia coli hemolysin (HlyA) to erythrocyte membranes. Infect. Immun. 58:1951-1958. - PMC - PubMed

Publication types

LinkOut - more resources